Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: A case report and review of the literature

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  de Vries, Iris A C ^a   van Acht, Marjolein M S ^a   Demeyere, Thomas B J ^a   Lybeert, Marnix L M ^a   de Zoete, Jean Paul ^a   Nieuwenhuijzen, Grard A P ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LOWER ABDOMINAL PAIN; RADIATION DOSE; SACRUM; TUMOR BIOPSY; TUMOR VOLUME; WEIGHT REDUCTION; ABDOMEN; ADJUVANT THERAPY; ANEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXOPHTHALMOS; HYPERTHYROIDISM; PATHOLOGY; RADIATION EXPOSURE; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ABDOMEN; AGED; ANEMIA; EXOPHTHALMOS; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; HYPERTHYROIDISM; NEOADJUVANT THERAPY; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77349085793     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-7     Document Type: Article

References (40)

1. Castleman B, Towne VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med 1954, 251(10):396-400.
2. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956, 9(4):822-830. 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4, 13356266.
3. Flendrig J. Benign giant lymphoma: clinicopathologic correlation study. 1970, 296-299. Chicago: Yearbook Medical Publishers.
4. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972, 29(3):670-683. 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#, 4551306.
5. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005, 129(1):3-17. 10.1111/j.1365-2141.2004.05311.x, 15801951.
6. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev 1995, 21(4):291-310. 10.1016/0305-7372(95)90034-9, 7585657.
7. Dispenzieri A, Gertz MA. Treatment of Castleman's disease. Curr Treat Options Oncol 2005, 6(3):255-266. 10.1007/s11864-005-0008-z, 15869736.
8. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978, 69(1):86-90.
9. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 1999, 85(3):706-717. 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7, 10091744.
10. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001, 92(3):670-676. 10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q, 11505414.
11. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998, 128(8):657-662.
12. Frizzera G. Castleman's disease: more questions than answers. Hum Pathol 1985, 16(3):202-205. 10.1016/S0046-8177(85)80002-2, 3871724.
13. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988, 5(4):346-364.
14. Humphreys SR, Holley KE, Smith LH, McIlrath DC. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephroitc syndrome. Mayo Clin Proc 1975, 50(6):317-321.
15. LeVan TA, Clifford S, Staren ED. Castleman's tumor masquerading as a pancreatic neoplasm. Surgery 1989, 106(5):884-887.
16. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol 1992, 5(5):525-530.
17. Seco JL, Velasco F, Manuel JS, Serrano SR, Tomas L, Velasco A. Retroperitoneal Castleman's disease. Surgery 1992, 112(5):850-855.
18. Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc 1995, 70(10):969-977. 10.4065/70.10.969, 7564550.
19. Shroff VJ, Gilchrist BF, DeLuca FG, McCombs HL, Wesselhoeft CW. Castleman's disease presenting as a pediatric surgical problem. J Pediatr Surg 1995, 30(5):745-747. 10.1016/0022-3468(95)90707-6, 7623245.
20. Martino G, Cariati S, Tintisona O, Veneroso S, De Villa F, Vergine M, Monti M. Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature. Tumori 2004, 90(3):352-355.
21. Gittinger JW. Ocular involvement in Castleman's disease. Response to radiotherapy. Ophthalmology 1989, 96(11):1646-1649.
22. Latz D, Mende U, Schraube P, Rieden K. [The radiotherapy of Castleman's lymphoma]. Strahlenther Onkol 1992, 168(5):297-299.
23. Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R. Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy. Cancer 1983, 51(5):808-810. 10.1002/1097-0142(19830301)51:5<808::AID-CNCR2820510510>3.0.CO;2-5, 6821846.
24. Massey GV, Kornstein MJ, Wahl D, Huang XL, McCrady CW, Carchman RA. Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings. Cancer 1991, 68(6):1365-1372. 10.1002/1097-0142(19910915)68:6<1365::AID-CNCR2820680630>3.0.CO;2-Q, 1873789.
25. Neuhof D, Debus J. Outcome and late complications of radiotherapy in patients with unicentric Castleman disease. Acta Oncol 2006, 45(8):1126-1131. 10.1080/02841860600812701, 17118850.
26. Nordstrom DG, Tewfik HH, Latourette HB. Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy. Int J Radiat Oncol Biol Phys 1978, 4(11-12):1045-1048.
27. Sethi T, Joshi K, Sharma SC, Gupta BD. Radiation therapy in the management of giant lymph node hyperplasia. Br J Radiol 1990, 63(752):648-650. 10.1259/0007-1285-63-752-648, 2400884.
28. Stokes SH, Griffith RC, Thomas PR. Angiofollicular lymph node hyperplasia (Castleman's disease) associated with vertebral destruction. Cancer 1985, 56(4):876-879. 10.1002/1097-0142(19850815)56:4<876::AID-CNCR2820560429>3.0.CO;2-C, 4016679.
29. Veldhuis GJ, Leest AH, de Wolf JT, de Vries EG, Vellenga E. A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol 1996, 73(1):47-50. 10.1007/s002770050201, 8695726.
30. Weisenburger DD, DeGowin RL, Gibson P, Armitage JO. Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer 1979, 44(2):457-462. 10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4, 476562.
31. Dispenzieri A. Castleman disease. Cancer Treat Res 2008, 142:293-330.
32. Nordstrom DG, Tewfik HH, Latourette HB. Plasma cell giant lymph node hyperplasia responding to radiation therapy. AJR Am J Roentgenol 1978, 130(1):169-171.
33. Yoshida K, Suzuki T, Sakata T, Kawai N, Matsuda A, Kayano H, Hirashima K, Matsutani M, Bessho M. Successful treatment of multicentric Castleman's disease with intracranial and retroperitoneal tumors. Intern Med 2001, 40(9):976-977. 10.2169/internalmedicine.40.976, 11579970.
34. Emson HE. Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis. Cancer 1973, 31(1):241-245. 10.1002/1097-0142(197301)31:1<241::AID-CNCR2820310132>3.0.CO;2-T, 4683040.
35. Fitzpatrick PJ, Brown TC. Angiofollicular lymph node hyperplasia. Can Med Assoc J 1968, 99(25):1259-1262. 1945616, 5700853.
36. Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg 2008, 248(2):243-251. 10.1097/SLA.0b013e31817fc2a0, 18650634.
37. Sadahiro S, Suzuki T, Ishikawa K, Yasuda S, Tajima T, Makuuchi H, Murayama C, Ohizumi Y. Intraoperative radiation therapy for curatively resected rectal cancer. Dis Colon Rectum 2001, 44(11):1689-1695. 10.1007/BF02234391, 11711743.
38. Stitzenberg KB, Klauber-Demore N, Chang XS, Calvo BF, Ollila DW, Goyal LK, Meyers MO, Kim HJ, Tepper JE, Sartor CI. In vivo intraoperative radiotherapy: a novel approach to radiotherapy for early stage breast cancer. Ann Surg Oncol 2007, 14(4):1515-1516. 10.1245/s10434-006-9152-3, 17235715.
39. Willett CG, Suit HD, Tepper JE, Mankin HJ, Convery K, Rosenberg AL, Wood WC. Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. Cancer 1991, 68(2):278-283. 10.1002/1097-0142(19910715)68:2<278::AID-CNCR2820680211>3.0.CO;2-C, 1906369.
40. Willett CG, Czito BG, Tyler DS. Intraoperative radiation therapy. J Clin Oncol 2007, 25(8):971-977. 10.1200/JCO.2006.10.0255, 17350946.